Resultado da Busca
The RoPE Score is a tool to identify patients with cryptogenic stroke and PFO who are likely to have a stroke caused by PFO. It uses clinical factors and Bayes' theorem to calculate the attributable fraction of PFO to the stroke.
14 de set. de 2020 · The RoPE score estimated attributable fraction is highly correlated to the relative risk reduction of device versus medical therapy. This observation suggests the RoPE score identifies patients with cryptogenic stroke who are likely to have a PFO that is pathogenic rather than incidental.
- David M. Kent, Jeffrey L. Saver, Robin Ruthazer, Anthony J. Furlan, Mark Reisman, John D. Carroll, R...
- 2020
The RoPE score ranges from 0 to 10, with scores of 0 to 3 indicating a negligible likelihood that the stroke is attributable to the PFO and a score of 10 indicating an approximately 90% probability that the stroke is attributable to the PFO.
27 de fev. de 2023 · This topic will review the approach to management of patients with an embolic-appearing ischemic stroke who have a patent foramen ovale (PFO) and no other apparent cause of stroke. The evaluation of patients with ischemic stroke and a PFO is reviewed elsewhere.
19 de mai. de 2022 · A RoPE (risk of paradoxical embolism) score ≥7 may identify patients who are likely to receive greater benefit from PFO closure. 2.2. In patients 60 years or older with a prior PFO-associated stroke, the SCAI guideline panel suggests PFO closure rather than long-term antiplatelet therapy alone (conditional recommendation, very low ...
21 de nov. de 2023 · Patients are classified as POSSIBLE in 2 scenarios: (1) high-risk PFO and a RoPE score <7 or (2) low-risk PFO (absence of a large shunt and ASA) and a RoPE score ≥7. POSSIBLE patients have a 62% relative reduction in recurrent ischemic stroke with closure.
23 de jan. de 2024 · Patent foramen ovale (PFO) is frequently identified in young patients with cryptogenic ischaemic stroke. Potential stroke mechanisms include paradoxical embolism from a venous clot which traverses the PFO, in situ clot formation within the PFO, and atrial arrhythmias due to electrical signalling disruption.
